SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 120 filers reported holding SERES THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,770,000 | +15.8% | 200,000 | 0.0% | 0.10% | +32.9% |
| Q1 2021 | $4,118,000 | -16.0% | 200,000 | 0.0% | 0.07% | -30.5% |
| Q4 2020 | $4,900,000 | -42.3% | 200,000 | -33.3% | 0.10% | -49.0% |
| Q3 2020 | $8,493,000 | +179.2% | 300,000 | 0.0% | 0.21% | +347.8% |
| Q4 2017 | $3,042,000 | -65.5% | 300,000 | -45.5% | 0.05% | -69.7% |
| Q3 2017 | $8,822,000 | +30.1% | 550,000 | -8.3% | 0.15% | +28.8% |
| Q2 2017 | $6,780,000 | +0.3% | 600,000 | 0.0% | 0.12% | -21.3% |
| Q1 2017 | $6,762,000 | -2.4% | 600,000 | -14.3% | 0.15% | -2.6% |
| Q4 2016 | $6,930,000 | +12.8% | 700,000 | +40.0% | 0.15% | +26.2% |
| Q3 2016 | $6,145,000 | -31.8% | 500,000 | +61.3% | 0.12% | -34.4% |
| Q2 2016 | $9,006,000 | +50.7% | 310,000 | +37.8% | 0.19% | +59.0% |
| Q1 2016 | $5,976,000 | -2.7% | 225,000 | +28.6% | 0.12% | +1.7% |
| Q4 2015 | $6,141,000 | +3.6% | 175,000 | -12.5% | 0.12% | -12.9% |
| Q3 2015 | $5,928,000 | -10.7% | 200,000 | +25.0% | 0.13% | -53.8% |
| Q2 2015 | $6,642,000 | – | 160,057 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |